Free Newsletter
Obama, McCain united against drug costs
Despite a lack of socialized medicine in the United States, the U.S. government pays a hefty 45 percent of the total expenditure of healthcare, and drugs represent a large percentage of the costs. Both Obama and McCain are prioritizing big pharma in their campaign goals to cut costs, which might be part of the reason for industry stock drops. Report
Comments
Post new comment
Paid Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact





